|
1
|
Head KA and Jurenka JS: Inflammatory bowel
disease Part I: ulcerative colitis - pathophysiology and
conventional and alternative treatment options. Altern Med Rev.
8:247–283. 2003.PubMed/NCBI
|
|
2
|
Lakatos L and Lakatos PL: Etiopathogenesis
of inflammatory bowel diseases. Orv Hetil. 144:1853–1860. 2003.(In
Hungarian).
|
|
3
|
Hugot JP: Inflammatory bowel disease:
causes and consequences. Best Pract Res Clin Gastroenterol.
18:447–479. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hugot JP and Thomas G: Genome-wide
scanning in inflammatory bowel diseases. Dig Dis. 16:364–369. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Annese V, Valvano MR, Palmieri O, Latiano
A, Bossa F and Andriulli A: Multidrug resistance 1 gene in
inflammatory bowel disease: a meta-analysis. World J Gastroenterol.
12:3636–3644. 2006.PubMed/NCBI
|
|
6
|
Jiang Y, Xia B, Jiang L, Lv M, Guo Q, Chen
M, Li J, Xia HH and Wong BC: Association of CTLA-4 gene
microsatellite polymorphism with ulcerative colitis in Chinese
patients. Inflamm Bowel Dis. 12:369–373. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Castro-Santos P, Suarez A, López-Rivas L,
Mozo L and Gutierrez C: TNFalpha and IL-10 gene polymorphisms in
inflammatory bowel disease. Association of −1082 AA low producer
IL-10 genotype with steroid dependency. Am J Gastroenterol.
101:1039–1047. 2006.
|
|
8
|
Pierik M, Joossens S, Van Steen K, Van
Schuerbeek N, Vlietinck R, Rutgeerts P and Vermeire S: Toll-like
receptor-1, -2, and -6 polymorphisms influence disease extension in
inflammatory bowel diseases. Inflamm Bowel Dis. 12:1–8. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takagawa T, Tamura K, Takeda N, Tomita T,
Ohda Y, Fukunaga K, Hida N, Ohnishi K, Hori K, Kosaka T, Fukuda Y,
Ikeuchi H, Yamamura T, Miwa H and Matsumoto T: Association between
IL-18 gene promoter polymorphisms and inflammatory bowel disease in
a Japanese population. Inflamm Bowel Dis. 11:1038–1043. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Török HP, Glas J, Tonenchi L, Mussack T
and Folwaczny C: Polymorphisms of the lipopolysaccharide-signaling
complex in inflammatory bowel disease: association of a mutation in
the Toll-like receptor 4 gene with ulcerative colitis. Clin
Immunol. 112:85–91. 2004.PubMed/NCBI
|
|
11
|
Obana N, Takahashi S, Kinouchi Y, Negoro
K, Takagi S, Hiwatashi N and Shimosegawa T: Ulcerative colitis is
associated with a promoter polymorphism of lipopolysaccharide
receptor gene, CD14. Scand J Gastroenterol. 37:699–704. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schall TJ, Bacon K, Toy KJ and Goeddel DV:
Selective attraction of monocytes and T lymphocytes of the memory
phenotype by cytokine RANTES. Nature. 347:669–671. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McCormack G, Moriarty D, O’Donoghue DP,
McCormick PA, Sheahan K and Baird AW: Tissue cytokine and chemokine
expression in inflammatory bowel disease. Inflamm Res. 50:491–495.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ansari N, Abdulla J, Zayyani N, Brahmi U,
Taha S and Satir AA: Comparison of RANTES expression in Crohn’s
disease and ulcerative colitis: an aid in the differential
diagnosis? J Clin Pathol. 59:1066–1072. 2006.PubMed/NCBI
|
|
15
|
Fägerstam JP, Whiss PA, Ström M and
Andersson RG: Expression of platelet P-selectin and detection of
soluble P-selectin, NPY and RANTES in patients with inflammatory
bowel disease. Inflamm Res. 49:466–472. 2000.PubMed/NCBI
|
|
16
|
Hizawa N, Yamaguchi E, Konno S, Tanino Y,
Jinushi E and Nishimura M: A functional polymorphism in the RANTES
gene promoter is associated with the development of late-onset
asthma. Am J Respir Crit Care Med. 166:686–690. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakajima K, Tanaka Y, Nomiyama T, Ogihara
T, Ikeda F, Kanno R, Iwashita N, Sakai K, Watada H, Onuma T and
Kawamori R: RANTES promoter genotype is associated with diabetic
nephropathy in type 2 diabetic subjects. Diabetes Care. 26:892–898.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nickel RG, Casolaro V, Wahn U, Beyer K,
Barnes KC, Plunkett BS, Freidhoff LR, Sengler C, Plitt JR,
Schleimer RP, Caraballo L, Naidu RP, Levett PN, Beaty TH and Huang
SK: Atopic dermatitis is associated with a functional mutation in
the promoter of the C-C chemokine RANTES. J Immunol. 164:1612–1616.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu H, Chao D, Nakayama EE, Taguchi H,
Goto M, Xin X, Takamatsu JK, Saito H, Ishikawa Y, Akaza T, Juji T,
Takebe Y, Ohishi T, Fukutake K, Maruyama Y, Yashiki S, Sonoda S,
Nakamura T, Nagai Y, Iwamoto A and Shioda T: Polymorphism in RANTES
chemokine promoter affects HIV-1 disease progression. Proc Natl
Acad Sci USA. 96:4581–4585. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McDermott DH, Beecroft MJ, Kleeberger CA,
Al-Sharif FM, Ollier WE, Zimmerman PA, Boatin BA, Leitman SF,
Detels R, Hajeer AH and Murphy PM: Chemokine RANTES promoter
polymorphism affects risk of both HIV infection and disease
progression in the Multicenter AIDS Cohort Study. AIDS.
14:2671–2678. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Podolsky DK: Inflammatory bowel disease
(2). N Engl J Med. 325:1008–1016. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Langholz E, Munkholm P, Davidsen M and
Binder V: Course of ulcerative colitis: analysis of changes in
disease activity over years. Gastroenterology. 107:3–11.
1994.PubMed/NCBI
|
|
23
|
Locati M, Deuschle U, Massardi ML,
Martinez FO, Sironi M, Sozzani S, Bartfai T and Mantovani A:
Analysis of the gene expression profile activated by the CC
chemokine ligand 5/RANTES and by lipopolysaccharide in human
monocytes. J Immunol. 168:3557–3562. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moriuchi H, Moriuchi M and Fauci AS:
Nuclear factor-kappa B potently up-regulates the promoter activity
of RANTES, a chemokine that blocks HIV infection. J Immunol.
158:3483–3491. 1997.PubMed/NCBI
|
|
25
|
al Sharif F, Ollier WE and Hajeer AH: A
rare polymorphism at position −28 in the human RANTES promoter. Eur
J Immunogenet. 26:373–374. 1999.
|
